These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16468640)
1. [Role of Ph-SA in enhancing bactericidal activity of beta-lactam antibiotics]. Tang XY; Zhang J; Guo L; Qiu XQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):48-51. PubMed ID: 16468640 [TBL] [Abstract][Full Text] [Related]
2. [Study on in vitro and in vivo antibacterial activity of pheromonicin-SA]. Huang Y; Zhang J; Dai P; Qiu XQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):749-52. PubMed ID: 15573744 [TBL] [Abstract][Full Text] [Related]
3. [Impact of Ph-SA on the expression of delta-toxin in Staphylococcus aureus]. Guo L; Zhang J; Tang XY; Qiu XQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):312-4. PubMed ID: 15931854 [TBL] [Abstract][Full Text] [Related]
4. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
5. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH; Lu CD Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056 [TBL] [Abstract][Full Text] [Related]
6. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora. Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284 [TBL] [Abstract][Full Text] [Related]
7. Screening for highly active beta-lactam antibiotics against Agrobacterium tumefaciens. Ogawa Y; Mii M Arch Microbiol; 2004 Apr; 181(4):331-6. PubMed ID: 14752589 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial and toxicological evaluation of beta-lactams synthesized by immobilized beta-lactamase-free penicillin amidase produced by Alcaligenes sp. Gayen JR; Majee SB; Das S; Samanta TB Indian J Exp Biol; 2007 Dec; 45(12):1068-72. PubMed ID: 18254214 [TBL] [Abstract][Full Text] [Related]
9. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci. Zhang HZ; Hackbarth CJ; Chansky KM; Chambers HF Science; 2001 Mar; 291(5510):1962-5. PubMed ID: 11239156 [TBL] [Abstract][Full Text] [Related]
11. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus. Kuroda M; Nagasaki S; Ohta T J Antimicrob Chemother; 2007 Mar; 59(3):425-32. PubMed ID: 17242033 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus. Inoue M; Suzuki T; Fujita Y; Oda M; Matsumoto N; Yamase T J Inorg Biochem; 2006 Jul; 100(7):1225-33. PubMed ID: 16563513 [TBL] [Abstract][Full Text] [Related]
13. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
15. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter. Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432 [No Abstract] [Full Text] [Related]
16. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE. Nakamura A; Oguri T; Misawa S; Tabe Y; Kondo S; Miyake K; Miyake N; Igari J; Ohsaka A Jpn J Antibiot; 2007 Jun; 60(3):153-60. PubMed ID: 17867489 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination. Jalil A; Niazi ID; Khan SU J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452 [TBL] [Abstract][Full Text] [Related]
18. Antibiogram and production of beta-lactamase by canine isolates of Staphylococcus aureus. Engvall A; Wierup M Nord Vet Med; 1982; 34(1-2):44-8. PubMed ID: 6979034 [TBL] [Abstract][Full Text] [Related]
19. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA). Murphy JT; Walshe R; Devocelle M J Theor Biol; 2008 Sep; 254(2):284-93. PubMed ID: 18577389 [TBL] [Abstract][Full Text] [Related]
20. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities. Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]